Welcome to our dedicated page for MMTEC news (Ticker: MTC), a resource for investors and traders seeking the latest updates and insights on MMTEC stock.
MMTEC, Inc. reports developments tied to its China-based financial-market technology and services business, including access to U.S. financial markets and placement-agent activity for financing transactions. Company updates also cover revenue categories, cost trends, and operating results disclosed through interim financial announcements.
Recurring MTC news includes Nasdaq minimum bid price compliance notices, hearings and related listing communications, the completed 1-for-8 reverse stock split of its common stock, capital-raising activity, and annual shareholder meeting matters.
MMTEC, Inc. (NASDAQ: MTC) reported a significant revenue increase of 85.35% to $329,070 for the first half of 2020, driven by brokerage service commissions post-acquisition of MMBD Trading Limited and MM Global Securities, Inc. Gross profit soared to $322,044, with a 97.86% gross margin. Although operating loss decreased to $1,041,361, the net loss narrowed to $1,011,152 or $0.05 per share. Future strategies include expanding asset management and enhancing services for Chinese investors seeking U.S. securities amidst trade tensions.
MMTEC, Inc. (MTC) announced an update to its August 10, 2020, press release regarding a Consulting Agreement with Hitek Global Inc. The Company will provide M&A, investment, financial, and strategic planning advice to Hitek for a consulting fee of $750,000. Hitek specializes in IT consulting and solutions for various industries in China. The agreement aims to enhance MMTEC's advisory and research capabilities.
MMTEC, Inc. (NasdaqCM:MTC), a technology company based in China, signed a three-month Consulting Services Agreement with Hitek Global Inc. for a consulting fee of $750,000. This collaboration aims to enhance MTC's investment banking capabilities in China by providing M&A, financial, and strategic planning advice. The company expects this engagement will facilitate in-depth investment research in various industries including healthcare and financial information services, assisting Chinese firms with capital market access.